Program Overview

The 2024 Glyco-Immunology Webinar Series consists of three free, two-hour public webinars that feature expert invited speakers and attendee question and answer periods. This series will highlight exciting questions and opportunities in the field of glyco-immunology, an emerging area within the field of immuno-oncology.

Problem Statement
With the recent development of new tools, researchers are now able to assess the role of tumor glycans on anti-tumor immunity and immune resistance. Despite its great potential to advance clinical and translational aspects of cancer immunotherapy, there is a marked lack of education and awareness within the field of immuno-oncology on glycobiology and its connection with the immune system, and the field of glyco-immunology remains largely nascent. The scientific community must effectively address and develop the field of glyco-immunology, generating more effective cancer immunotherapies and improving patient outcomes.

Series Goals and Learning Objectives
The primary objective of the SITC SfG Glyco-Immunology Webinar Series is to highlight clinical and translational opportunities and challenges in the field of glyco-immunology. Secondary goals and learning objectives include:

• Defining the impact of glycans on anti-tumor immunity and immune resistance
• Applying principles of glyco-immunology to develop more effective cancer immunotherapies
• Establishing SITC as a home for researchers and healthcare providers interested in glyco-immunology and cancer immunotherapy.

Organizer and Faculty